Frequent co‐inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours
Authors:
- 13 December 2014
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 67 (1) , 121-129
Abstract
Aims: Malignant rhabdoid tumours (MRTs) are highly aggressive malignancies of early infancy characterized by inactivation of SMARCB1, a core member of the SWI/SNF chromatin‐remodelling complex. The aim of this study was to explore the status of multiple key subunits of the SWI/SNF complex in MRTs.Methods and results: We screened the key subunits of the SWI/SNF complex, including SMARCB1, SMARCA2, PBRM1, SMARCA4, and ARID1A, in four MRTs by immunohistochemistry, sequencing, and fluorescence in‐situ hybridization (FISH). Complete loss of SMARCB1, SMARCA2 and PBRM1 expression and corresponding mutations in the same genes were observed in all cases. The mutations included seven missense, three same‐sense, four frameshift and two truncating mutations. FISH revealed heterozygous deletion of SMARCB1 in one case, and monoploidy of chromosome 22, which harbours SMARCB1, in another case. Furthermore, trisomy of chromosome 9, which harbours SMARCA2, was observed in two cases. Abnormality of PBRM1 was not found in any case.Conclusions: We report, for the first time, co‐inactivation and frequent mutations of SMARCB1, SMARCA2 and PBRM1 in MRTs. Multiple subunit abnormalities of the SWI/SNF complex potentially act together to contribute to the tumorigenesis of MRTs, which provides unique insights into this disease.Keywords
Funding Information
- National Natural Science Foundation of China (81472391)
- National Natural Science Foundation of China (81101933)
- National Natural Science Foundation of China (81171391)
- National Natural Science Foundation of China (81372743)
- National Natural Science Foundation of China (81201187)
This publication has 39 references indexed in Scilit:
- SMARCB1 Deficiency in Tumors From the Peripheral Nervous SystemAmerican Journal of Surgical Pathology, 2012
- SMARCB1/INI1 inactivation in renal medullary carcinomaHistopathology, 2012
- Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategyOncogene, 2011
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinomaNature, 2011
- ARID1AMutations in Endometriosis-Associated Ovarian CarcinomasNew England Journal of Medicine, 2010
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell CarcinomaScience, 2010
- Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescenceProceedings of the National Academy of Sciences, 2010
- Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition SyndromeThe American Journal of Human Genetics, 2010
- The SWI/SNF complex and cancerOncogene, 2009
- BAF180 Is a Critical Regulator of p21 Induction and a Tumor Suppressor Mutated in Breast CancerCancer Research, 2008